advertisement
Torrejon KY 17
Showing records 1 to 17 | Display all abstracts from Torrejon KY117135 ANGPTL7 and Its Role in IOP and Glaucoma
Brown SF
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Galli C; Bastia E
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Nguyen H
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Hubatsch DA
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Mzyk P; Mzyk P; De Ieso ML
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Toris C
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Unser AM
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Fan S
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Brown I
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Unser A
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Ramesh P
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Ahmed F
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Afzaal H
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Torrejon KY
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Ahmed F
Investigative Ophthalmology and Visual Science 2024; 65: 22
118704 NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Impagnatiello F
Journal of Ocular Pharmacology and Therapeutics 2024; 40: 389-396
117135 ANGPTL7 and Its Role in IOP and Glaucoma
Torrejon KY; Nhan A; Markrush D; Daly T; Knecht E; McConaughy W; Halmos S; Liu ZL; Rennard R; Peterson A; Stamer WD
Investigative Ophthalmology and Visual Science 2024; 65: 22
